Shanghai Medicilon Inc. (SHA:688202)
62.70
+1.10 (1.79%)
At close: Aug 4, 2025, 2:57 PM CST
Shanghai Medicilon Market Cap
Shanghai Medicilon has a market cap or net worth of 7.73 billion as of August 8, 2025. Its market cap has increased by 97.90% in one year.
Market Cap
7.73B
Enterprise Value
7.37B
Revenue
1.04B
Ranking
n/a
PE Ratio
n/a
Stock Price
62.70
Market Cap Chart
Since November 5, 2019, Shanghai Medicilon's market cap has increased from 4.40B to 7.73B, an increase of 75.52%. That is a compound annual growth rate of 10.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 7.73B | 91.58% |
Dec 31, 2024 | 4.03B | -56.21% |
Dec 29, 2023 | 9.21B | -50.52% |
Dec 30, 2022 | 18.61B | -38.26% |
Dec 31, 2021 | 30.15B | 209.24% |
Dec 31, 2020 | 9.75B | 169.46% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 411.71B |
Shenzhen Mindray Bio-Medical Electronics | 275.78B |
WuXi AppTec | 267.08B |
Sichuan Biokin Pharmaceutical | 122.78B |
Zhangzhou Pientzehuang Pharmaceutical., | 121.57B |
Aier Eye Hospital Group | 119.17B |
Shanghai United Imaging Healthcare | 105.91B |
Yunnan Baiyao Group Co.,Ltd | 99.85B |